CBD may play a role in treating canine coronavirus

CBD may not in itself offer a cure for the devastating coronavirus
in humans, but it may play a larger role in treating canine coronavirus,
experts say. The interplay between coronavirus in animals — such as fowl, dogs,
pigs and cows — and humans is still being studied and may have played a role in
the current global spread of the disease. While CBD is not a cure for coronavirus
in humans, it has properties that address key elements. CBD is known to offer anti-viral,
anti-inflammatory and anti-bacterial properties. It also acts as an effective
treatment for nausea and vomiting, which can be induced by the coronavirus in
humans.

The impact of the coronavirus
globally has also intensified coverage of CBD according to companies such
as stockmarketpress.com
which features coverage of CBD related stocks like CBD
Unlimited, Inc. (OTC PINK: EDXC), Canopy Growth Corp. (NYSE: CGC), New Age
Beverages Corp. (NASDAQ: NBEV), GW Pharmaceuticals PLC (NASDAQ: GWPH), Neptune
Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT). Aurora Cannabis Inc.
(NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC:SPRWF) and OrganiGram Holdings
Inc. (NASDAQ: OGI).

CBD’s role in fighting canine coronavirus

In dogs, the canine coronavirus is
an intestinal infection which can be transmitted by exposure to the feces of an
infected dog according to the site thoughtcloud.net. Overcrowding and unsanitary conditions can
also be factors in its transmission, experts report. While CBD may not be a
cure for coronavirus in humans, it may play a larger role in treating canine coronavirus.

CBD can help fight canine coronavirus, due to its anti-inflammatory and
antiemetic properties. CBD oil also has antiviral properties making it a potent
cannabinoid to fight the virus. CBD can also fight the feeling of nausea in
dogs suffering from canine coronavirus. A veterinarian may prescribe
antibiotics, too. While CBD may not be a cure for coronavirus in humans, it may
play a larger role in treating canine coronavirus. It has qualities associated
with painkilling, anti-viral, anti-nausea and may even strengthen the immune system.

CBD Unlimited, Inc. (otc pink:EDXC) identified the CBD pet
market as an important opportunity. It produces and markets a line of CBD
chews, oils and equine products that bring the benefits of CBD to pets. The
Brightfield Group estimates that the U.S. pet CBD market will reach $1.7
billion by 2023. That’s quick growth because according to the corporate
presentation of CBD Unlimited, Inc. (otc pink:EDXC) the pet CBD market was at
some $500 million last year. Reaching $1.7 billion in a few years means that
the CBD pet market is exploding in sales. The company explains that its pet CBD
products are hemp-derived, THC free and specifically formulated for pets and
equines.

While CBD is not seen as a cure for the coronavirus in
humans, it has numerous important properties that address issues felt by
individuals who contract the illness, experts said. While CBD may not be a cure
for coronavirus, it offers anti-viral, anti-inflammatory and anti-bacterial
properties. These are significant for people who contract the coronavirus and
become nauseas, vomit, and experience any inflammation. Also, CBD is known to
reduce stress and anxiety issues. All of these properties are helpful in
fighting the disease. The coronavirus (COVID19) could become a worldwide
pandemic.

CBD Unlimited, Inc. (OTC PINK: EDXC) makes sure its CBD
products — whether marketed for humans or pets — are highest quality,
American-manufactured and tightly controlled by a seed-to-shelf strategy,
meaning its hemp is certified and grown in Colorado and Kentucky. It has
premium genetics and superior quality, the company said in its recent corporate
presentation. Its extracts in processing are rich in phyto-cannabinoids and
terpenoids which are non-psychoactive. The product is also cGMP Certified (Good
Manufacturing Practice Certification).

Source: Stock Market Press (stockmarketpress.com), 110 Wall St., New York, NY 10005 email: info@stockmarketpress.com

Stock Market Press is a financial
news company that delivers up to date stock news, introduces private and public
companies to a wide audience of investors, consumers, journalists and the
general public via social media and a rapidly expanding network.

Safe Harbor Statement: Statements in
this news release may be ”forward-looking statements.” Forward-looking
statements include, but are not limited to, statements that express our
intentions, beliefs, expectations, strategies, predictions or any other
statements relating to our future activities or other future events or
conditions. These statements are based on current expectations, estimates and
projections about our business based, in part, on assumptions made by
management. These statements are not guarantees of future performance and
involve risks, uncertainties and assumptions that are difficult to predict.
Therefore, actual outcomes and results may, and are likely to, differ
materially from what is expressed or forecasted in forward-looking statements
due to numerous factors. Any forward-looking statements speak only as of the
date of this news release and Stock Market Press undertakes no obligation to
update any forward-looking statement to reflect events or circumstances after
the date of this news release.